Folgen
Erin Rayment
Erin Rayment
Executive Director, Industry Engagement, Queensland University of Technology
Bestätigte E-Mail-Adresse bei qut.edu.au
Titel
Zitiert von
Zitiert von
Jahr
Increased matrix metalloproteinase‐9 (MMP‐9) activity observed in chronic wound fluid is related to the clinical severity of the ulcer
EA Rayment, Z Upton, GK Shooter
British Journal of Dermatology 158 (5), 951-961, 2008
2832008
Concise review: mind the gap: challenges in characterizing and quantifying cell-and tissue-based therapies for clinical translation
EA Rayment, DJ Williams
Stem Cells 28 (5), 996-1004, 2010
1252010
Precision manufacturing for clinical-quality regenerative medicines
DJ Williams, RJ Thomas, PC Hourd, A Chandra, E Ratcliffe, Y Liu, ...
Philosophical Transactions of the Royal Society A: Mathematical, Physical …, 2012
802012
Attenuation of protease activity in chronic wound fluid with bisphosphonate-functionalised hydrogels
EA Rayment, TR Dargaville, GK Shooter, GA George, Z Upton
Biomaterials 29 (12), 1785-1795, 2008
642008
Finding the culprit: a review of the influences of proteases on the chronic wound environment
EA Rayment, Z Upton
The international journal of lower extremity wounds 8 (1), 19-27, 2009
612009
Human pilot studies reveal the potential of a vitronectin: growth factor complex as a treatment for chronic wounds
Z Upton, HJ Wallace, GK Shooter, DR van Lonkhuyzen, S Yeoh‐Ellerton, ...
International wound journal 8 (5), 522-532, 2011
462011
Regenerative medicine, resource and regulation: lessons learned from the remedi project
PJ Ginty, EA Rayment, P Hourd, DJ Williams
Regenerative Medicine 6 (2), 241-253, 2011
252011
Qualification of academic facilities for small-scale automated manufacture of autologous cell-based products
P Hourd, A Chandra, D Alvey, P Ginty, M McCall, E Ratcliffe, E Rayment, ...
Regenerative medicine 9 (6), 799-815, 2014
192014
Application of response surface methodology to maximize the productivity of scalable automated human embryonic stem cell manufacture
E Ratcliffe, P Hourd, J Guijarro-Leach, E Rayment, DJ Williams, ...
Regenerative medicine 8 (1), 39-48, 2013
172013
Investigation into the proteolytic activity in chronic wound fluid and development of a remediation strategy
EA Rayment
Queensland University of Technology, 2007
22007
Wound repair composition and method
EA Rayment, T Dargaville, Z Upton
US Patent 8,747,830, 2014
12014
Wound repair composition and method
EA Rayment, T Dargaville, Z Upton
US Patent 8,747,830, 2014
12014
Wound repair composition and method
EA Rayment, T Dargaville, Z Upton
US Patent 8,747,830, 2014
12014
Wound repair composition and method
EA Rayment, T Dargaville, Z Upton
US Patent 8,747,830, 2014
12014
Pleasant encounters of the VM kind: leveraging on NeCTAR VMs to achieve research outcomes
F Gacenga, N Kelly, E Rayment
eResearch Australasia 2014 Conference, 2014
2014
eCM XI: Multi-axial bioreactor for nucleus pulposus tissue engineering
MW Naing, Y Liu, EA Rayment, DJ Williams
European Cells and Materials 20 (SUPPL 2), 54, 2010
2010
A potential treatment for chronic leg ulcers using alendronate-functionalised hydrogels as novel wound dressings
EA Rayment, TR Dargaville, GK Shooter, GA George, Z Upton
WOUND REPAIR AND REGENERATION 16 (4), A63-A63, 2008
2008
11. Acne, Psoriasis, and Disorders of Keratinization
EA Rayment, Z Upton, GK Shooter
Br J Dermatol 158 (5), 951-961, 2008
2008
Elevated matrix-metalloproteinase activity in chronic wound fluid
EA Rayment, GK Shooter, GA George, Z Upton
European Tissue Repair Society, 2006
2006
Analysis of aqueous PEG-HEMA wound dressing synthesis, protein release and biocompatibility in a three-dimensional skin model
EA Rayment, Z Upton, GA George
2006
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20